471 results on '"Gatter KC"'
Search Results
2. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival
3. The diagnosis of low-grade peripheral B-cell neoplasms in bone marrow trephines
4. Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer
5. Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells: Research paper
6. An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin's disease
7. Ways of escape: are all tumours angiogenic?
8. The Angiogenesis Regulator and Notch Pathway Activator Delta like Ligand 4 (DII4) Is Widely Expressed by Vascular and Neoplastic Cells in Human Cancer and Relocates to the Nucleus. An Immunohistochemical and In-Situ Hybridization Study
9. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients
10. Expression of VEGF, its receptors and hypoxia inducible factors in acute myeloblastic leukaemia
11. Vascular endothelial growth factor expression in lung cancer
12. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration
13. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases
14. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease
15. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer
16. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy
17. Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer
18. The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers
19. Cell Proliferation in Lymphomas
20. p53 expression in colorectal adenomas
21. Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39
22. Human AP endonuclease 1 (HAP1) protein expression in breast cancer correlates with lymph node status and angiogenesis
23. The angiogenic factor platelet-derived endothelial cell growth factor thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium
24. Lymphoma Classification Proposal - Clarification
25. A Revised European-american Classification of Lymphoid Neoplasms Proposed By the International Lymphoma Study-group - a Summary Version
26. Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome
27. A Revised European-american Classification of Lymphoid Neoplasms - a Proposal From the International Lymphoma Study-group
28. Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer
29. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival
30. Human AP endonuclease 1 (HAP1) protein expression in breast cancer correlates with lymph node status and angiogenesis
31. Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer
32. Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance
33. Anomalous retinoblastoma protein expression in Sternberg-Reed cells in Hodgkin's disease: a comparative study with p53 and Ki67 expression
34. Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124)
35. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium
36. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer
37. Lymphoma classification proposal: clarification [letter; comment] [see comments]
38. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]
39. The relationship of p53 immunostaining to survival in carcinoma of the lung
40. Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer
41. Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis
42. Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma
43. Peripheral T-cell lymphoma associated with hemophagocytic syndrome [see comments]
44. Use of monoclonal antibodies for the histopathological diagnosis of human malignancy.
45. Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.
46. Carcinoma of the cervix uteri: an assessment of tumour proliferation using the monoclonal antibody Ki67.
47. Value of monoclonal anti-CD22 (p135) antibodies for the detection of normal and neoplastic B lymphoid cells
48. Dr Gatter replies as follows
49. Coexpression of hypoxia-inducible factors 1 alpha and 2 alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival
50. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.